» Articles » PMID: 31173553

Decoding Metastatic Colorectal Cancer to Improve Clinical Decision Making

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2019 Jun 8
PMID 31173553
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.

Nagaoka T, Osumi H, Ueno T, Ooki A, Wakatsuki T, Nakayama I Int J Clin Oncol. 2023; 28(9):1191-1199.

PMID: 37349660 DOI: 10.1007/s10147-023-02370-6.


Case Report: Long-term survival of a patient with advanced rectal cancer and multiple pelvic recurrences after seven surgeries.

Ouyang Y, Zhu Y, Chen H, Li G, Hu X, Luo H Front Oncol. 2023; 13:1169616.

PMID: 37256170 PMC: 10225707. DOI: 10.3389/fonc.2023.1169616.


Neoadjuvant immunotherapy in primary and metastatic colorectal cancer.

Kanani A, Veen T, Soreide K Br J Surg. 2021; 108(12):1417-1425.

PMID: 34694371 PMC: 10364874. DOI: 10.1093/bjs/znab342.


Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.

Supplitt S, Karpinski P, Sasiadek M, Laczmanska I Int J Mol Sci. 2021; 22(3).

PMID: 33572595 PMC: 7866970. DOI: 10.3390/ijms22031422.